A detailed history of Jane Street Group, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 400,509 shares of BAX stock, worth $15.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
400,509
Previous 101,091 296.19%
Holding current value
$15.8 Million
Previous $4.32 Million 210.12%
% of portfolio
0.02%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $9.84 Million - $13 Million
299,418 Added 296.19%
400,509 $13.4 Million
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $11.5 Million - $13.3 Million
-303,911 Reduced 75.04%
101,091 $4.32 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $11.1 Million - $13.6 Million
348,760 Added 620.11%
405,002 $15.7 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $10.7 Million - $14.2 Million
-287,959 Reduced 83.66%
56,242 $2.12 Million
Q2 2023

Aug 14, 2023

SELL
$39.98 - $47.68 $7.64 Million - $9.11 Million
-191,056 Reduced 35.69%
344,201 $15.7 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $10.4 Million - $14.6 Million
276,979 Added 107.24%
535,257 $21.7 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $4.89 Million - $5.67 Million
98,331 Added 61.48%
258,278 $13.2 Million
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $5.53 Million - $6.85 Million
-102,613 Reduced 39.08%
159,947 $8.62 Million
Q2 2022

Aug 16, 2022

SELL
$63.83 - $80.0 $101 Million - $127 Million
-1,581,974 Reduced 85.77%
262,560 $16.9 Million
Q1 2022

May 17, 2022

BUY
$76.85 - $89.45 $132 Million - $154 Million
1,721,702 Added 1401.67%
1,844,534 $143 Million
Q4 2021

Feb 15, 2022

SELL
$74.57 - $87.19 $12.9 Million - $15.1 Million
-172,912 Reduced 58.47%
122,832 $10.5 Million
Q3 2021

Nov 16, 2021

BUY
$73.77 - $83.61 $3.45 Million - $3.91 Million
46,722 Added 18.76%
295,744 $23.8 Million
Q2 2021

Aug 16, 2021

BUY
$80.5 - $88.01 $10.6 Million - $11.6 Million
131,976 Added 112.76%
249,022 $20 Million
Q1 2021

May 18, 2021

BUY
$76.38 - $86.03 $8.34 Million - $9.39 Million
109,141 Added 1380.66%
117,046 $9.87 Million
Q4 2020

Feb 17, 2021

SELL
$75.39 - $82.36 $13.6 Million - $14.8 Million
-179,895 Reduced 95.79%
7,905 $634,000
Q3 2020

Nov 17, 2020

BUY
$78.33 - $90.73 $14.5 Million - $16.8 Million
184,885 Added 6342.54%
187,800 $15.1 Million
Q2 2020

Aug 17, 2020

SELL
$78.66 - $94.14 $2.09 Million - $2.5 Million
-26,538 Reduced 90.1%
2,915 $251,000
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $2.18 Million - $2.84 Million
-30,394 Reduced 50.79%
29,453 $2.39 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $3.83 Million - $4.42 Million
49,938 Added 503.97%
59,847 $5.01 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $3.13 Million - $3.46 Million
-38,502 Reduced 79.53%
9,909 $867,000
Q2 2019

Aug 15, 2019

SELL
$73.44 - $82.41 $3.64 Million - $4.09 Million
-49,624 Reduced 50.62%
48,411 $3.97 Million
Q1 2019

May 16, 2019

BUY
$64.48 - $81.31 $4.98 Million - $6.28 Million
77,281 Added 372.37%
98,035 $7.97 Million
Q4 2018

Feb 15, 2019

BUY
$61.45 - $77.8 $563,865 - $713,892
9,176 Added 79.25%
20,754 $1.37 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $1.74 Million - $1.91 Million
-24,581 Reduced 67.98%
11,578 $893,000
Q2 2018

Aug 15, 2018

SELL
$63.43 - $75.41 $835,626 - $993,451
-13,174 Reduced 26.7%
36,159 $2.67 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $294,907 - $340,633
-4,714 Reduced 8.72%
49,333 $3.21 Million
Q4 2017

Feb 15, 2018

BUY
$61.45 - $66.05 $2.53 Million - $2.72 Million
41,245 Added 322.18%
54,047 $3.49 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $761,719 - $827,137
12,802
12,802 $803,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.